Form 8-K - Current report:
SEC Accession No. 0001193125-25-124488
Filing Date
2025-05-22
Accepted
2025-05-22 06:10:45
Documents
17
Period of Report
2025-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d928340d8k.htm   iXBRL 8-K 69251
2 EX-2.1 d928340dex21.htm EX-2.1 644843
3 EX-10.1 d928340dex101.htm EX-10.1 23864
4 EX-99.1 d928340dex991.htm EX-99.1 48393
5 EX-99.2 d928340dex992.htm EX-99.2 28093
9 GRAPHIC g928340g0521221228751.jpg GRAPHIC 4129
  Complete submission text file 0001193125-25-124488.txt   1141995

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vigl-20250521.xsd EX-101.SCH 2860
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20250521_lab.xml EX-101.LAB 19501
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20250521_pre.xml EX-101.PRE 12163
20 EXTRACTED XBRL INSTANCE DOCUMENT d928340d8k_htm.xml XML 3961
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 25974674
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)